Koyfin Home > Directory > Health Care > Adma Biologics > Price / Sales (ntm)

Adma Biologics Price / Sales (ntm) Chart (ADMA)

Adma Biologics annual/quarterly Price / Sales (ntm) from 2013 to 2020.
  • Adma Biologics Price / Sales (ntm) for the quarter ending October 10, 2020 was 3.36 a -9.22% decrease of -0.31 year over year
  • Adma Biologics Price / Sales (ntm) for the last 12 months ending October 10, 2020 was 3.36 a -9.22% decrease of -0.31 year over year
  • Adma Biologics Annual Price / Sales (ntm) for 2020 was 3.36 a -3.40% decrease of -0.11 from 2019
  • Adma Biologics Annual Price / Sales (ntm) for 2020 was 3.47 a -3.29% decrease of -0.11 from 2019
  • Adma Biologics Annual Price / Sales (ntm) for 2020 was 3.59 a -2.27% decrease of -0.08 from 2019
Other Valuation Metrics:
  • Adma Biologics Market Cap for the quarter ending March 03, 2018 was $208m a 54.25% increase of 113m year over year
  • Adma Biologics Price / Book for the quarter ending March 03, 2018 was 5.17 a -360.96% decrease of -18.66 year over year
  • Adma Biologics Enterprise Value for the quarter ending March 03, 2018 was $206m a 49.35% increase of 101m year over year
View Chart On Koyfin

Quarterly ADMA Price / Sales (ntm) Data

10/20203.36
10/20203.47
10/20203.59
10/20203.67
10/20203.73
10/20203.53
10/20203.59
10/20203.65
10/20203.70
10/20203.81

Annual ADMA Price / Sales (ntm) Data

20203.36
20203.47
20203.59
20203.67
20203.73
20203.53
20203.59
20203.65
20203.70
20203.81